Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study

Journal of Neuroinflammation

Volumn 8, Issue , 2011, Pages

  Brochu, Marie Elsa ^a   Girard, Sylvie ^a   Lavoie, Karine ^a   Sébire, Guillaume ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT; CYTOKINE INDUCED NEUTROPHIL CHEMOATTRACTANT 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN DEVELOPMENT; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; DEVELOPMENTAL STAGE; EXPERIMENTAL STUDY; MEMBRANE PERMEABILITY; NEUROMODULATION; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; ANIMAL; BRAIN; CAPILLARY PERMEABILITY; DRUG EFFECT; FEMALE; HUMAN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; IMMUNOLOGY; INFLAMMATION; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; PREMATURITY; RAT;

ANIMALS; ANIMALS, NEWBORN; BLOOD-BRAIN BARRIER; BRAIN; CAPILLARY PERMEABILITY; CYTOKINES; FEMALE; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION; LIPOPOLYSACCHARIDES; MODELS, ANIMAL; NEUTROPHIL INFILTRATION; RATS;

EID: 79956194621     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-8-55     Document Type: Article

References (69)

1. Yuan TM, Sun Y, Zhan CY, Yu HM. Intrauterine infection/inflammation and perinatal brain damage: role of glial cells and Toll-like receptor signaling. J Neuroimmunol 2010, 229:16-25. 10.1016/j.jneuroim.2010.08.008, 20826013.
2. Nelson KB. Can we prevent cerebral palsy?. N Engl J Med 2003, 349:1765-1769. 10.1056/NEJMsb035364, 14585946.
3. Ferriero DM. Neonatal brain injury. N Engl J Med 2004, 351:1985-1995. 10.1056/NEJMra041996, 15525724.
4. Volpe JJ. Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurol 2009, 8:110-124. 10.1016/S1474-4422(08)70294-1, 2707149, 19081519.
5. Back SA, Riddle A, McClure MM. Maturation-dependent vulnerability of perinatal white matter in premature birth. Stroke 2007, 38:724-730. 10.1161/01.STR.0000254729.27386.05, 17261726.
6. Glass HC, Bonifacio SL, Chau V, Glidden D, Poskitt K, Barkovich AJ, Ferriero DM, Miller SP. Recurrent postnatal infections are associated with progressive white matter injury in premature infants. Pediatrics 2008, 122:299-305. 10.1542/peds.2007-2184, 18676547.
7. Girard S, Tremblay L, Lepage M, Sebire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 2010, 184:3997-4005. 10.4049/jimmunol.0903349, 20181892.
8. Fan LW, Tien LT, Zheng B, Pang Y, Rhodes PG, Cai Z. Interleukin-1beta-induced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by alpha-phenyl-n-tert-butyl-nitrone. Neuroscience 2010, 168:240-252. 10.1016/j.neuroscience.2010.03.024, 20346393.
9. Wang X, Stridh L, Li W, Dean J, Elmgren A, Gan L, Eriksson K, Hagberg H, Mallard C. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J Immunol 2009, 183:7471-7477. 10.4049/jimmunol.0900762, 19917690.
10. Aden U, Favrais G, Plaisant F, Winerdal M, Felderhoff-Mueser U, Lampa J, Lelievre V, Gressens P. Systemic inflammation sensitizes the neonatal brain to excitotoxicity through a pro-/anti-inflammatory imbalance: key role of TNFalpha pathway and protection by etanercept. Brain Behav Immun 2010, 24:747-758. 10.1016/j.bbi.2009.10.010, 19861157.
11. Fan LW, Mitchell HJ, Tien LT, Rhodes PG, Cai Z. Interleukin-1beta-induced brain injury in the neonatal rat can be ameliorated by alpha-phenyl-n-tert-butyl-nitrone. Exp Neurol 2009, 220:143-153. 10.1016/j.expneurol.2009.08.003, 2761495, 19682987.
12. Cai Z, Lin S, Pang Y, Rhodes PG. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 2004, 56:377-384. 10.1203/01.PDR.0000134249.92944.14, 15201401.
13. Dammann O, Leviton A. Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences. Early Hum Dev 2004, 79:1-15. 10.1016/j.earlhumdev.2004.04.009, 15282118.
14. Baud O, Emilie D, Pelletier E, Lacaze-Masmonteil T, Zupan V, Fernandez H, Dehan M, Frydman R, Ville Y. Amniotic fluid concentrations of interleukin-1beta, interleukin-6 and TNF-alpha in chorioamnionitis before 32 weeks of gestation: histological associations and neonatal outcome. Br J Obstet Gynaecol 1999, 106:72-77. 10.1111/j.1471-0528.1999.tb08088.x, 10426263.
15. Bracci R, Buonocore G. Chorioamnionitis: a risk factor for fetal and neonatal morbidity. Biol Neonate 2003, 83:85-96. 10.1159/000067956, 12576751.
16. Grether JK, Nelson KB. Maternal infection and cerebral palsy in infants of normal birth weight. JAMA 1997, 278:207-211. 10.1001/jama.278.3.207, 9218666.
17. Kadhim H, Tabarki B, De Prez C, Sebire G. Cytokine immunoreactivity in cortical and subcortical neurons in periventricular leukomalacia: are cytokines implicated in neuronal dysfunction in cerebral palsy?. Acta Neuropathol 2003, 105:209-216.
18. Kadhim H, Tabarki B, Verellen G, De Prez C, Rona AM, Sebire G. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001, 56:1278-1284.
19. Nelson KB, Grether JK, Dambrosia JM, Walsh E, Kohler S, Satyanarayana G, Nelson PG, Dickens BF, Phillips TM. Neonatal cytokines and cerebral palsy in very preterm infants. Pediatr Res 2003, 53:600-607. 10.1203/01.PDR.0000056802.22454.AB, 12612192.
20. Wu YW, Escobar GJ, Grether JK, Croen LA, Greene JD, Newman TB. Chorioamnionitis and cerebral palsy in term and near-term infants. JAMA 2003, 290:2677-2684. 10.1001/jama.290.20.2677, 14645309.
21. Yoon BH, Park CW, Chaiworapongsa T. Intrauterine infection and the development of cerebral palsy. BJOG 2003, 110(Suppl 20):124-127.
22. Kadhim H, Khalifa M, Deltenre P, Casimir G, Sebire G. Molecular mechanisms of cell death in periventricular leukomalacia. Neurology 2006, 67:293-299. 10.1212/01.wnl.0000224754.63593.c4, 16864823.
23. Girard S, Sebire G, Kadhim H. Proinflammatory orientation of the interleukin 1 system and downstream induction of matrix metalloproteinase 9 in the pathophysiology of human perinatal white matter damage. J Neuropathol Exp Neurol 2010, 69:1116-1129. 10.1097/NEN.0b013e3181f971e4, 20940629.
24. Meng SZ, Takashima S. Expression of transforming growth factor-beta 1 in periventricular leukomalacia. J Child Neurol 1999, 14:377-381. 10.1177/088307389901400606, 10385845.
25. Pang Y, Fan LW, Zheng B, Cai Z, Rhodes PG. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience 2006, 141:745-755. 10.1016/j.neuroscience.2006.04.007, 16713113.
26. Mecha M, Rabadan MA, Pena-Melian A, Valencia M, Mondejar T, Blanco MJ. Expression of TGF-betas in the embryonic nervous system: analysis of interbalance between isoforms. Dev Dyn 2008, 237:1709-1717. 10.1002/dvdy.21558, 18498095.
27. Gadient RA, Otten U. Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Res 1994, 637:10-14. 10.1016/0006-8993(94)91211-4, 8180786.
28. Marz P, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 1999, 26:191-200. 10.1002/(SICI)1098-1136(199905)26:3<191::AID-GLIA1>3.0.CO;2-#, 10340760.
29. Zhao B, Schwartz JP. Involvement of cytokines in normal CNS development and neurological diseases: recent progress and perspectives. J Neurosci Res 1998, 52:7-16. 10.1002/(SICI)1097-4547(19980401)52:1<7::AID-JNR2>3.0.CO;2-I, 9556025.
30. Zocchia C, Spiga G, Rabin SJ, Grekova M, Richert J, Chernyshev O, Colton C, Mocchetti I. Biological activity of interleukin-10 in the central nervous system. Neurochem Int 1997, 30:433-439. 10.1016/S0197-0186(96)00079-4, 9106258.
31. Knoblach SM, Faden AI. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury. Exp Neurol 1998, 153:143-151. 10.1006/exnr.1998.6877, 9743576.
32. Mehler MF, Kessler JA. Cytokines in brain development and function. Adv Protein Chem 1998, 52:223-251.
33. Pang Y, Rodts-Palenik S, Cai Z, Bennett WA, Rhodes PG. Suppression of glial activation is involved in the protection of IL-10 on maternal E. coli induced neonatal white matter injury. Brain Res Dev Brain Res 2005, 157:141-149.
34. Mesples B, Plaisant F, Gressens P. Effects of interleukin-10 on neonatal excitotoxic brain lesions in mice. Brain Res Dev Brain Res 2003, 141:25-32.
35. Gadient RA, Otten UH. Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials. Prog Neurobiol 1997, 52:379-390. 10.1016/S0301-0082(97)00021-X, 9304698.
36. Suzuki S, Tanaka K, Suzuki N. Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects. J Cereb Blood Flow Metab 2009, 29:464-479. 10.1038/jcbfm.2008.141, 19018268.
37. Vannucci RC, Connor JR, Mauger DT, Palmer C, Smith MB, Towfighi J, Vannucci SJ. Rat model of perinatal hypoxic-ischemic brain damage. J Neurosci Res 1999, 55:158-163. 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1, 9972818.
38. Larouche A, Roy M, Kadhim H, Tsanaclis AM, Fortin D, Sebire G. Neuronal injuries induced by perinatal hypoxic-ischemic insults are potentiated by prenatal exposure to lipopolysaccharide: animal model for perinatally acquired encephalopathy. Dev Neurosci 2005, 27:134-142. 10.1159/000085985, 16046847.
39. Girard S, Kadhim H, Larouche A, Roy M, Gobeil F, Sebire G. Pro-inflammatory disequilibrium of the IL-1 beta/IL-1ra ratio in an experimental model of perinatal brain damages induced by lipopolysaccharide and hypoxia-ischemia. Cytokine 2008, 43:54-62. 10.1016/j.cyto.2008.04.007, 18511291.
40. Girard S, Kadhim H, Beaudet N, Sarret P, Sebire G. Developmental motor deficits induced by combined fetal exposure to lipopolysaccharide and early neonatal hypoxia/ischemia: a novel animal model for cerebral palsy in very premature infants. Neuroscience 2009, 158:673-682. 10.1016/j.neuroscience.2008.10.032, 19010395.
41. Blamire AM, Anthony DC, Rajagopalan B, Sibson NR, Perry VH, Styles P. Interleukin-1beta -induced changes in blood-brain barrier permeability, apparent diffusion coefficient, and cerebral blood volume in the rat brain: a magnetic resonance study. J Neurosci 2000, 20:8153-8159.
42. Anthony D, Dempster R, Fearn S, Clements J, Wells G, Perry VH, Walker K. CXC chemokines generate age-related increases in neutrophil-mediated brain inflammation and blood-brain barrier breakdown. Curr Biol 1998, 8:923-926. 10.1016/S0960-9822(07)00373-9, 9707404.
43. Folkerth RD. Neuropathologic substrate of cerebral palsy. J Child Neurol 2005, 20:940-949. 10.1177/08830738050200120301, 16417840.
44. Zhu Y, Yang GY, Ahlemeyer B, Pang L, Che XM, Culmsee C, Klumpp S, Krieglstein J. Transforming growth factor-beta 1 increases bad phosphorylation and protects neurons against damage. J Neurosci 2002, 22:3898-3909.
45. Boche D, Cunningham C, Gauldie J, Perry VH. Transforming growth factor-beta 1-mediated neuroprotection against excitotoxic injury in vivo. J Cereb Blood Flow Metab 2003, 23:1174-1182.
46. Henrich-Noack P, Prehn JH, Krieglstein J. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 1996, 27:1609-1614. discussion 1615.
47. Herrmann O, Tarabin V, Suzuki S, Attigah N, Coserea I, Schneider A, Vogel J, Prinz S, Schwab S, Monyer H, et al. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in cerebral ischemia. J Cereb Blood Flow Metab 2003, 23:406-415.
48. Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 2003, 140:471-476. 10.1038/sj.bjp.0705462, 1574053, 12970087.
49. Froen JF, Munkeby BH, Stray-Pedersen B, Saugstad OD. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res 2002, 942:87-94. 10.1016/S0006-8993(02)02700-2, 12031856.
50. Spera PA, Ellison JA, Feuerstein GZ, Barone FC. IL-10 reduces rat brain injury following focal stroke. Neurosci Lett 1998, 251:189-192. 10.1016/S0304-3940(98)00537-0, 9726375.
51. Ali C, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, Buisson A, Vivien D. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab 2000, 20:956-966.
52. Clark WM, Rinker LG, Lessov NS, Hazel K, Hill JK, Stenzel-Poore M, Eckenstein F. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000, 31:1715-1720.
53. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1998, 18:176-179.
54. Folkerth RD, Trachtenberg FL, Haynes RL. Oxidative injury in the cerebral cortex and subplate neurons in periventricular leukomalacia. J Neuropathol Exp Neurol 2008, 67:677-686. 10.1097/NEN.0b013e31817e5c5e, 2831221, 18596545.
55. Campbell SJ, Wilcockson DC, Butchart AG, Perry VH, Anthony DC. Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J Neurochem 2002, 83:432-441. 10.1046/j.1471-4159.2002.01166.x, 12423253.
56. Campbell SJ, Perry VH, Pitossi FJ, Butchart AG, Chertoff M, Waters S, Dempster R, Anthony DC. Central nervous system injury triggers hepatic CC and CXC chemokine expression that is associated with leukocyte mobilization and recruitment to both the central nervous system and the liver. Am J Pathol 2005, 166:1487-1497. 10.1016/S0002-9440(10)62365-6, 1606402, 15855648.
57. Towfighi J, Mauger D, Vannucci RC, Vannucci SJ. Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia-ischemia: a light microscopic study. Brain Res Dev Brain Res 1997, 100:149-160.
58. Schultz C, Temming P, Bucsky P, Gopel W, Strunk T, Hartel C. Immature anti-inflammatory response in neonates. Clin Exp Immunol 2004, 135:130-136. 10.1111/j.1365-2249.2004.02313.x, 1808915, 14678274.
59. Levy O. Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 2007, 7:379-390. 10.1038/nri2075, 17457344.
60. Leviton A, Fichorova R, Yamamoto Y, Allred EN, Dammann O, Hecht J, Kuban K, McElrath T, O'Shea TM, Paneth N. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine 2011, 53:66-73. 10.1016/j.cyto.2010.09.003, 20934883.
61. Qiu L, Zhu C, Wang X, Xu F, Eriksson PS, Nilsson M, Cooper-Kuhn CM, Kuhn HG, Blomgren K. Less neurogenesis and inflammation in the immature than in the juvenile brain after cerebral hypoxia-ischemia. J Cereb Blood Flow Metab 2007, 27:785-794.
62. Anthony DC, Bolton SJ, Fearn S, Perry VH. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 1997, 120(Pt 3):435-444.
63. Lawson LJ, Perry VH. The unique characteristics of inflammatory responses in mouse brain are acquired during postnatal development. Eur J Neurosci 1995, 7:1584-1595. 10.1111/j.1460-9568.1995.tb01154.x, 7551185.
64. Towfighi J, Zec N, Yager J, Housman C, Vannucci RC. Temporal evolution of neuropathologic changes in an immature rat model of cerebral hypoxia: a light microscopic study. Acta Neuropathol 1995, 90:375-386. 10.1007/BF00315011, 8546028.
65. Hickey E, Shi H, Van Arsdell G, Askalan R. Lipopolysaccharide-induced preconditioning ischemic injury is associated with changes in Toll-like receptor 4 expression int the rat developing brain. Pediatr Res 2011, 70:1-5.
66. Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J. The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997, 41:607-616. 10.1203/00006450-199705000-00002, 9128280.
67. Bona E, Andersson AL, Blomgren K, Gilland E, Puka-Sundvall M, Gustafson K, Hagberg H. Chemokine and inflammatory cell response to hypoxia-ischemia in immature rats. Pediatr Res 1999, 45:500-509. 10.1203/00006450-199904010-00008, 10203141.
68. Benjelloun N, Renolleau S, Represa A, Ben-Ari Y, Charriaut-Marlangue C. Inflammatory responses in the cerebral cortex after ischemia in the P7 neonatal Rat. Stroke 1999, 30:1916-1923. discussion 1923-1914.
69. Vexler ZS, Yenari MA. Does inflammation after stroke affect the developing brain differently than adult brain?. Dev Neurosci 2009, 31:378-393. 10.1159/000232556, 2790734, 19672067.